ARCHIVES

In Brief: Duke’s Gary Lyman to Co-Direct Fred Hutch Outcomes Research

This article is from The Cancer Letter archive.

Vol. 40 No. 02 | January 10, 2014

Download PDF Visit The Full Archive

Related Articles

AACI Asks NCI to Reconsider Dropping CCPDS Support, Find New Mechanism to Fund Center Outreach Effort

July 9, 1982

RFA: Long-Term Cancer Survivors

September 12, 1997

Unwanted Distinction: MSKCC Bars Zaltrap From Formulary, Triggering Debate Over Drug Pricing

November 1, 2012

House Committee Investigates ESA Safety, Urges Amgen, J&J, To Stop Promotions.

March 23, 2007

Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum

January 8, 1993

Harkin to Ask NCI For Accounting Of Antineoplaston Trials

July 2, 1993